MFAM
GMED icon

Motley Fool Asset Management’s Globus Medical GMED Stock Holding History

Motley Fool Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$227K Buy
2,637
+335
+15% +$30.1K 0.01% 230
2025
Q4 		$201K Buy
+2,302
New +$175K 0.01% 239
2025
Q3 		– Sell
-33,469
Closed -$1.98M – 243
2025
Q2 		$1.98M Sell
33,469
-123,809
-79% -$8M 0.09% 153
2025
Q1 		$11.5M Sell
157,278
-14,170
-8% -$1.17M 0.65% 31
2024
Q4 		$14.2M Buy
171,448
+15,240
+10% +$1.2M 0.74% 28
2024
Q3 		$11M Sell
156,208
-44,942
-22% -$3.17M 0.65% 39
2024
Q2 		$13.7M Sell
201,150
-12,667
-6% -$757K 0.91% 26
2024
Q1 		$11.5M Buy
213,817
+151,623
+244% +$8.15M 0.74% 38
2023
Q4 		$3.31M Buy
62,194
+13,943
+29% +$680K 0.25% 85
2023
Q3 		$2.4M Buy
48,251
+1,540
+3% +$86.1K 0.19% 93
2023
Q2 		$2.78M Sell
46,711
-564
-1% -$32.1K 0.25% 78
2023
Q1 		$2.68M Sell
47,275
-3,384
-7% -$217K 0.3% 69
2022
Q4 		$3.76M Sell
50,659
-5,068
-9% -$345K 0.42% 57
2022
Q3 		$3.32M Sell
55,727
-2,697
-5% -$162K 0.33% 69
2022
Q2 		$3.35M Sell
58,424
-5,624
-9% -$370K 0.32% 72
2022
Q1 		$4.72M Sell
64,048
-12,842
-17% -$893K 0.35% 65
2021
Q4 		$5.55M Sell
76,890
-3,911
-5% -$284K 0.35% 75
2021
Q3 		$6.19M Sell
80,801
-1,323
-2% -$106K 0.4% 64
2021
Q2 		$6.37M Sell
82,124
-4,410
-5% -$314K 0.42% 62
2021
Q1 		$5.34M Buy
86,534
+13,230
+18% +$838K 0.38% 70
2020
Q4 		$4.78M Buy
73,304
+13,230
+22% +$761K 0.36% 69
2020
Q3 		$2.95M Buy
60,074
+21,333
+55% +$1.1M 0.26% 78
2020
Q2 		$1.85M Buy
38,741
+3,355
+9% +$162K 0.18% 83
2020
Q1 		$1.5M Sell
35,386
-305
-0.9% -$15.1K 0.2% 82
2019
Q4 		$2.1M Sell
35,691
-1,220
-3% -$66.2K 0.23% 80
2019
Q3 		$1.89M Sell
36,911
-610
-2% -$29.1K 0.22% 74
2019
Q2 		$1.59M Buy
37,521
+610
+2% +$26.5K 0.18% 85
2019
Q1 		$1.82M Buy
36,911
+6,100
+20% +$276K 0.21% 84
2018
Q4 		$1.33M Buy
+30,811
New +$1.54M 0.19% 84

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Motley Fool Asset Management's GMED Position: Q1 2026 in Review

Motley Fool Asset Management increased its Globus Medical (GMED) stake by 15% in Q1 2026, buying an estimated $30.1K and bringing the position to 2,637 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #230.

Motley Fool Asset Management first reported a position in GMED in Q4 2018 and has held it in 29 quarters since. The position peaked at $14.2M in Q4 2024. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Motley Fool Asset Management held 2,637 shares of Globus Medical worth $227K as of Q1 2026.
  • Motley Fool Asset Management bought 335 Globus Medical shares in Q1 2026, an estimated $30.1K.
  • Globus Medical made up 0.01% of Motley Fool Asset Management's portfolio in Q1 2026, its #230 holding.
  • Motley Fool Asset Management first reported a position in Globus Medical in Q4 2018 and has held it in 29 quarters since.
  • Motley Fool Asset Management's Globus Medical position peaked at $14.2M in Q4 2024.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Motley Fool Asset Management's 13F filing for Q1 2026, filed 12 May 2026.